Trinol 35mg Tablet MR
Marketer
Knoll Pharmaceuticals Ltd
Salt Composition
Trimetazidine (35mg)
Overview Trinol 35mg Tablet MR
Cardio-Ease 35mg Extended-Release Tablets are prescribed for angina pectoris, a type of chest pain linked to the heart. This medication acts as a preventative measure against angina episodes but won't alleviate an attack already in progress. It may be used independently or alongside other cardiac medications, as determined by your physician. Consistent daily intake, as directed, is crucial. Consumption with or without food is acceptable, maintaining a regular schedule. Your dosage frequency might adjust based on treatment effectiveness. Continuous use, even during symptom-free periods, maximizes its protective benefits. Discontinuing treatment may trigger a recurrence of chest pain. Complementing medication with a heart-healthy lifestyle – including smoking cessation, moderate alcohol consumption, a balanced diet, regular physical activity, and stress management – is highly beneficial. Potential side effects include lightheadedness, headache, stomach upset, diarrhea, indigestion, nausea, vomiting, skin rash, itching, urticaria, and fatigue. Report any persistent or bothersome side effects to your doctor. This medication isn't appropriate for everyone; inform your physician of any existing liver or kidney conditions, pregnancy, breastfeeding, or concurrent medications.
Primary Ingredients of Trinol 35mg Tablet MR
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Trinol 35mg Tablet MR
Managing chest pain associated with angina pectoris
Major Benefits of Trinol 35mg Tablet MR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Trinol 35mg Modified-Release tablet should be taken with a meal.
Common Side effects of Trinol 35mg Tablet MR:
- Dizziness
- Headache
- Nausea
- Vomiting
- Weakness
- Rash
- Abdominal pain
- Indigestion
- Itching
- Diarrhea
- Hives
How to use Trinol 35mg Tablet MR:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Trinol 35mg Modified-Release Tablet should be taken with a meal.
How Trinol 35mg Tablet MR works:
Trinol 35mg Modified-Release tablets offer anti-anginal relief. Their mechanism involves altering cardiac metabolism, prioritizing glucose over fats as fuel, thus reducing the heart's oxygen demand and improving its overall performance.
SAFETY ADVICE
AlcoholUNSAFE
Concomitant use of Trinol 35mg modified-release tablets and alcohol can lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Data on Trinol 35mg MR Tablet use in pregnancy is absent. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Trinol 35mg Tablet MR use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Extended-release Trinol 35mg tablets can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with kidney impairment should use Trinol 35mg Modified-Release tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. Trinol 35mg Modified-Release tablets are contraindicated in individuals with severe kidney disease.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Trinol 35mg Tablet MR in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Trinol 35mg Tablet MR :
Should you forget to take your Trinol 35mg Modified-Release Tablet, ingest it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Trinol 35mg Tablet MR
| Label | Value |
|---|---|
| Chemical Category | Benzylamines |
| Developing Habits | No. |
| Treatment Category | HEART |
| Action Category | Fatty acid regulator and sodium channel antagonist |





